Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tevogen Inc. before investing.

In this article, we go over a few key elements for understanding Tevogen Inc.’s stock price such as:

• Tevogen Inc.’s current stock price and volume
• Why Tevogen Inc.’s stock price changed recently
• Upgrades and downgrades for TVGN from analysts
• TVGN’s stock price momentum as measured by its relative strength

About Tevogen Inc. (TVGN)

Before we jump into Tevogen Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.

Want to learn more about Tevogen Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Tevogen Inc..

Tevogen Inc.’s Stock Price as of Market Close

As of September 11, 2026, 4:00 PM, CST, Tevogen Inc.’s stock price was $7.360.

Tevogen Inc. is up 0.96% from its previous closing price of $7.290.

During the last market session, Tevogen Inc.’s stock traded between $6.970 and $7.900. Currently, there are approximately 3.83 million shares outstanding for Tevogen Inc..

Tevogen Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Tevogen Inc. Stock Price History

Tevogen Inc.’s (TVGN) price is currently up 5.44% so far this month.

During the month of September, Tevogen Inc.’s stock price has reached a high of $7.900 and a low of $6.720.

Over the last year, Tevogen Inc. has hit prices as high as $44.135 and as low as $3.636. Year to date, Tevogen Inc.’s stock is down 55.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Tevogen Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 11, 2026, there were analysts who downgraded Tevogen Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Tevogen Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Tevogen Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Tevogen Inc. (TVGN) by visiting AAII Stock Evaluator.

Relative Price Strength of Tevogen Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 11, 2026, Tevogen Inc. has a weighted four-quarter relative price strength of -23.40%, which translates to a Momentum Score of 10 and is considered to be Very Weak.

Want to learn more about how Tevogen Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Tevogen Inc. Stock Price: Bottom Line

As of September 11, 2026, Tevogen Inc.’s stock price is $7.360, which is up 0.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Tevogen Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.